Pharmaceutical

Cellectis to focus on CAR-T cell therapies in 2023

Cellectis provided updates for the three CAR-T cell therapies trials, with the three trials recruiting across various cancer indications.

Aug 4, 2023 - 20:00
Cellectis to focus on CAR-T cell therapies in 2023
Cellectis provided updates for the three CAR-T cell therapies trials, with the three trials recruiting across various cancer indications.
Read the original article

Tags:

Previous Article

Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK

Next Article

Gilead reports 8.45% dip in net income for Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Atossa Therapeutics progresses Phase II preventative breast cancer therapy

Atossa Therapeutics progresses Phase II preventative br...

Jan 27, 2024

Intra-Cellular bolsters Caplyta data with another Phase III win

Intra-Cellular bolsters Caplyta data with another Phase...

Nov 7, 2024

STAT+: Generic group sues Minnesota over a drug pricing transparency law it calls an ‘unconstitutional overreach’

STAT+: Generic group sues Minnesota over a drug pricing...

Jul 6, 2023